Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda

Simple item page
dc.contributor.authorWanyenze, Rhoda K.
dc.contributor.authorBwanika, John Baptist
dc.contributor.authorBeyeza-Kashesya, Jolly
dc.contributor.authorMugerwa, Shaban
dc.contributor.authorArinaitwe, Jim
dc.contributor.authorMatovu, Joseph K. B.
dc.contributor.authorGwokyalya, Violet
dc.contributor.authorKasozi, Dickson
dc.contributor.authorBukenya, Justine
dc.contributor.authorMakumb, Fred
dc.date.accessioned2018-08-08T06:46:22Z
dc.date.available2018-08-08T06:46:22Z
dc.date.issued2017-10
dc.descriptionThis study assessed uptake and correlates of cervical screening among HIV infected women in care in Uganda.en_US
dc.description.abstractObjective: This study assessed uptake and correlates of cervical screening among HIV-infected women in care in Uganda. Methods: A nationally representative cross-sectional survey of HIV-infected women in care was conducted from August to November 2016. Structured interviews were conducted with 5198 women aged 15–49 years, from 245 HIV clinics. Knowledge and uptake of cervical screening and human papillomavirus (HPV) vaccination were determined. Correlates of cervical screening were assessed with modified Poisson regression to obtain prevalence ratios (PRs) using Stata version 12.0. Results: Overall, 94.0% (n = 4858) had ever heard of cervical screening and 66% (n = 3732) knew a screening site. However, 47.4% (n = 2302) did not know the schedule for screening and 50% (n = 2409) did not know the symptoms of cervical cancer. One-third (33.7%; n = 1719) rated their risk of cervical cancer as low. Uptake of screening was 30.3% (n = 1561). Women who had never been screened cited lack of information (29.6%; n = 1059) and no time (25.5%; n = 913) as the main reasons. Increased likelihood of screening was associated with receipt of HIV care at a level II health center [adj. PR 1.89, 95% confidence interval (CI) 1.29–2.76] and private facilities (adj. PR 1.68, 95% CI 1.16–3.21), knowledge of cervical screening (adj. PR 2.19, 95% CI 1.78–2.70), where to go for screening (adj. PR 6.47, 95% CI 3.69–11.36), and low perception of risk (adj. PR 1.52, 95% CI 1.14–2.03). HPV vaccination was 2%. Conclusions: Cervical screening and HPV vaccination uptake were very low among HIV-infected women in care in Uganda. Improved knowledge of cervical screening schedules and sites, and addressing fears and risk perception may increase uptake of cervical screening in this vulnerable population.en_US
dc.identifier.citationWanyenze, Rhoda K., Bwanika, John Baptist, Beyeza-Kashesya, Jolly, Mugerwa, Shaban, Arinaitwe, Jim, Matovu, Joseph K. B., Gwokyalya, Violet, Kasozi, Dickson, Bukenya, Justine, Makumbi, Fred, 2017. Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda.en_US
dc.identifier.urihttps://hdl.handle.net/20.500.11951/348
dc.language.isoenen_US
dc.publisherTaylor & Francis Onlineen_US
dc.subjectCervical canceren_US
dc.subjectCervical cancer screeningen_US
dc.subjectHIV-infected womenen_US
dc.titleUptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Ugandaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Wanyenze et al._Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda_2017.pdf
Size:
1.24 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.97 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
UCU School of Medicine